| Year |
Citation |
Score |
| 2020 |
Winthrop KL, Brunton AE, Beekmann S, Polgreen P, Baddley J, Saag KG, Calabrese C, Calabrese L, Robinson PC, Wallace ZS, Curtis JR. SARS CoV-2 infection among patients using immunomodulatory therapies. Annals of the Rheumatic Diseases. PMID 32759259 DOI: 10.1136/Annrheumdis-2020-218580 |
0.324 |
|
| 2020 |
Rosas G, Gaffo A, Rahn EJ, Saag KG. Cardiovascular safety risks associated with gout treatments. Expert Opinion On Drug Safety. PMID 32731769 DOI: 10.1080/14740338.2020.1804551 |
0.31 |
|
| 2020 |
Bar M, Ott SM, Lewiecki EM, Sarafoglou K, Wu JY, Thompson MJ, Vaux JJ, Dean DR, Saag KG, Hashmi SK, Inamoto Y, Dholaria BR, Kharfan-Dabaja MA, Nagler A, Rodriguez C, et al. Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32653624 DOI: 10.1016/J.Bbmt.2020.07.001 |
0.326 |
|
| 2020 |
Saag KG, Williams SA, Wang Y, Weiss RJ, Cauley JA. Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture. Clinical Therapeutics. PMID 32513495 DOI: 10.1016/J.Clinthera.2020.04.012 |
0.377 |
|
| 2020 |
Conley RB, Adib G, Adler RA, Åkesson KE, Alexander IM, Amenta KC, Blank RD, Brox WT, Carmody EE, Chapman-Novakofski K, Clarke BL, Cody KM, Cooper C, Crandall CJ, Dirschl DR, ... ... Saag K, et al. Secondary Fracture Prevention: Consensus Clinical Recommendations From a Multistakeholder Coalition. Orthopedic Nursing. 39: 145-161. PMID 32443087 DOI: 10.1097/Nor.0000000000000672 |
0.321 |
|
| 2020 |
Wright NC, Chen L, Saag KG, Brown CJ, Shikany JM, Curtis JR. Racial Disparities Exist in Outcomes After Major Fragility Fractures. Journal of the American Geriatrics Society. PMID 32337717 DOI: 10.1111/Jgs.16455 |
0.323 |
|
| 2020 |
Conley RB, Adib G, Adler RA, Åkesson KE, Alexander IM, Amenta KC, Blank RD, Brox WT, Carmody EE, Chapman-Novakofski K, Clarke BL, Cody KM, Cooper C, Crandall CJ, Dirschl DR, ... ... Saag K, et al. Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition. Journal of Orthopaedic Trauma. 34: e125-e141. PMID 32195892 DOI: 10.1097/Bot.0000000000001743 |
0.405 |
|
| 2020 |
Danila MI, Saag KG. Imminent Fracture Risk: A Call to Action for Rheumatologists. Arthritis Care & Research. 72: 741-743. PMID 32100968 DOI: 10.1002/Acr.24171 |
0.323 |
|
| 2020 |
Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F, ... ... Saag K, et al. Correction to: Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 32065251 DOI: 10.1007/S00198-020-05297-0 |
0.311 |
|
| 2020 |
Adami G, Saag KG, Mudano AS, Rahn EJ, Wright NC, Outman RC, Greenspan SL, LaCroix AZ, Nieves JW, Silverman SL, Siris ES, Watts NB, Miller MJ, Ladores S, Curtis JR, et al. Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 32020264 DOI: 10.1007/S00198-020-05312-4 |
0.349 |
|
| 2020 |
Curtis JR, Saag KG, Arora T, Wright NC, Yun H, Daigle S, Matthews R, Delzell E. Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk. Medical Care. PMID 31985584 DOI: 10.1097/Mlr.0000000000001294 |
0.337 |
|
| 2019 |
Singh JA, Lemay CA, Nobel L, Yang W, Weissman N, Saag KG, Allison J, Franklin PD. Association of Early Postoperative Pain Trajectories With Longer-term Pain Outcome After Primary Total Knee Arthroplasty. Jama Network Open. 2: e1915105. PMID 31722026 DOI: 10.1001/jamanetworkopen.2019.15105 |
0.629 |
|
| 2019 |
Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F, ... ... Saag K, et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 31720707 DOI: 10.1007/S00198-019-05176-3 |
0.349 |
|
| 2019 |
Adami G, Jaleel A, Curtis JR, Delzell E, Chen R, Yun H, Daigle S, Arora T, Danila MI, Wright NC, Cadarette SM, Mudano A, Foster J, Saag KG. Temporal trends and factors associated with bisphosphonate discontinuation and restart. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31714637 DOI: 10.1002/Jbmr.3915 |
0.344 |
|
| 2019 |
Adami G, Saag KG, Chapurlat RD, Guañabens N, Haugeberg G, Lems WF, Matijevic R, Peel N, Poddubnyy D, Geusens P. Balancing benefits and risks in the era of biologics. Therapeutic Advances in Musculoskeletal Disease. 11: 1759720X19883973. PMID 31695755 DOI: 10.1177/1759720X19883973 |
0.32 |
|
| 2019 |
McClung MR, O'Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, Reid IR, Kiel DP, Cavallari I, Bonaca MP, Wiviott SD, de Villiers T, Ling X, Lippuner K, Nakamura T, et al. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. The Lancet. Diabetes & Endocrinology. PMID 31676222 DOI: 10.1016/S2213-8587(19)30346-8 |
0.349 |
|
| 2019 |
Adami G, Rahn EJ, Saag KG. Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice. Therapeutic Advances in Musculoskeletal Disease. 11: 1759720X19876468. PMID 31565078 DOI: 10.1177/1759720X19876468 |
0.318 |
|
| 2019 |
Conley RB, Adib G, Adler RA, Akesson KE, Alexander IM, Amenta KC, Blank RD, Brox WT, Carmody EE, Chapman-Novakofski K, Clarke BL, Cody KM, Cooper C, Crandall CJ, Dirschl DR, ... ... Saag K, et al. Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31538675 DOI: 10.1002/Jbmr.3877 |
0.402 |
|
| 2019 |
Edmonds S, Lou Y, Robinson B, Cram P, Roblin DW, Wright NC, Saag K, Wolinsky FD. Characteristics of older adults using patient web portals to view their DXA results. Bmc Medical Informatics and Decision Making. 19: 187. PMID 31533717 DOI: 10.1186/S12911-019-0904-Y |
0.309 |
|
| 2019 |
Wallace BI, Lin P, Kamdar N, Noureldin M, Hayward R, Fox DA, Curtis JR, Saag KG, Waljee AK. Patterns of glucocorticoid prescribing and provider-level variation in a commercially insured incident rheumatoid arthritis population: A retrospective cohort study. Seminars in Arthritis and Rheumatism. PMID 31522762 DOI: 10.1016/J.Semarthrit.2019.09.002 |
0.315 |
|
| 2019 |
Adami G, Saag KG. Glucocorticoid-induced osteoporosis update. Current Opinion in Rheumatology. 31: 388-393. PMID 31045947 DOI: 10.1097/Bor.0000000000000608 |
0.316 |
|
| 2019 |
Wu CH, Chang YF, Chen CH, Lewiecki EM, Wüster C, Reid I, Tsai KS, Matsumoto T, Mercado-Asis LB, Chan DC, Hwang JS, Cheung CL, Saag K, Lee JK, Tu ST, et al. Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region. Journal of Clinical Densitometry : the Official Journal of the International Society For Clinical Densitometry. PMID 31010789 DOI: 10.1016/J.Jocd.2019.03.004 |
0.391 |
|
| 2019 |
Wright NC, Blackston JW, Saag KG. Changing rates in fracture trends are temporally associated with declining testing and treatment: reality or ecologic fallacy? Current Opinion in Rheumatology. 31: 316-320. PMID 30920974 DOI: 10.1097/Bor.0000000000000596 |
0.321 |
|
| 2019 |
Saag KG, Pannacciulli N, Geusens P, Adachi JD, Messina OD, Morales-Torres J, Emkey R, Butler PW, Yin X, Lems WF. Denosumab vs risedronate in glucocorticoid-induced osteoporosis: final results of a 24-month randomized, double-blind, double-dummy trial. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30816640 DOI: 10.1002/Art.40874 |
0.311 |
|
| 2019 |
Adami G, Saag KG. Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporosis International. 30: 1145-1156. PMID 30805679 DOI: 10.1007/S00198-019-04906-X |
0.413 |
|
| 2019 |
Pisu M, Kopperdahl DL, Lewis CE, Saag KG, Keaveny TM. Cost-effectiveness of osteoporosis screening using biomechanical computed tomography for patients with a previous abdominal CT. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 30779860 DOI: 10.1002/Jbmr.3700 |
0.346 |
|
| 2019 |
Wright NC, Melton ME, Sohail M, Herbey I, Davies S, Levitan EB, Saag KG, Ivankova NV. Race Plays a Role in the Knowledge, Attitudes, and Beliefs of Women with Osteoporosis. Journal of Racial and Ethnic Health Disparities. PMID 30747331 DOI: 10.1007/S40615-019-00569-W |
0.318 |
|
| 2019 |
Silverman S, Langdahl BL, Fujiwara S, Saag K, Napoli N, Soen S, Enomoto H, Melby TE, Disch DP, Marin F, Krege JH. Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational Studies. Calcified Tissue International. 104: 193-200. PMID 30343436 DOI: 10.1007/S00223-018-0485-2 |
0.356 |
|
| 2019 |
Saag K, Williams S, Wang Y, Weiss R, Cauley J. SAT-519 Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture Representative of Covered Commercial Insurance Enrollees Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sat-519 |
0.371 |
|
| 2019 |
Adami G, Jaleel A, Curtis J, Chen R, Yun H, Daigle S, Arora T, Danila M, Wright N, Cadarette S, Mudano A, Foster J, Saag K. Op0082 Temporal Trends Of Bisphosphonate Discontinuation And Factors Associated With Alendronate Discontinuation And Restart At Population Level Annals of the Rheumatic Diseases. 78: 113-114. DOI: 10.1136/Annrheumdis-2019-Eular.1626 |
0.37 |
|
| 2018 |
Schnell AD, Curtis JR, Saag KG. Importance of Recent Fracture as Predictor of Imminent Fracture Risk. Current Osteoporosis Reports. PMID 30368717 DOI: 10.1007/S11914-018-0487-Z |
0.328 |
|
| 2018 |
Hall SF, Wright NC, Wolinsky FD, Lou Y, Edmonds S, Roblin D, Jones M, Saag K, Cram P. The prevalence of overtreatment of osteoporosis: results from the PAADRN trial. Archives of Osteoporosis. 13: 103. PMID 30267162 DOI: 10.1007/S11657-018-0517-6 |
0.357 |
|
| 2018 |
Jaleel A, Saag KG, Danila MI. Improving drug adherence in osteoporosis: an update on more recent studies. Therapeutic Advances in Musculoskeletal Disease. 10: 141-149. PMID 30023009 DOI: 10.1177/1759720X18785539 |
0.35 |
|
| 2018 |
Langdahl BL, Silverman S, Fujiwara S, Saag K, Napoli N, Soen S, Enomoto H, Melby TE, Disch DP, Marin F, Krege JH. Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies. Bone. 116: 58-66. PMID 30021126 DOI: 10.1016/J.Bone.2018.07.013 |
0.361 |
|
| 2018 |
Balasubramanian A, Wade SW, Adler RA, Saag K, Pannacciulli N, Curtis JR. Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 29924418 DOI: 10.1002/Jbmr.3523 |
0.323 |
|
| 2018 |
Bone HG, Cosman F, Miller PD, Williams GC, Hattersley G, Hu MY, Fitzpatrick LA, Mitlak B, Papapoulos S, Rizzoli R, Dore RK, Bilezikian JP, Saag KG. ACTIVExtend: 24 Months of Alendronate after 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis. The Journal of Clinical Endocrinology and Metabolism. PMID 29800372 DOI: 10.1210/Jc.2018-00163 |
0.301 |
|
| 2018 |
Saag KG, Wagman RB, Geusens P, Adachi JD, Messina OD, Emkey R, Chapurlat R, Wang A, Pannacciulli N, Lems WF. Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study. The Lancet. Diabetes & Endocrinology. 6: 445-454. PMID 29631782 DOI: 10.1016/S2213-8587(18)30075-5 |
0.335 |
|
| 2018 |
White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, Hunt B, Castillo M, Gunawardhana L. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout. The New England Journal of Medicine. PMID 29527974 DOI: 10.1056/Nejmoa1710895 |
0.314 |
|
| 2018 |
Danila MI, Outman RC, Rahn EJ, Mudano AS, Redden DT, Li P, Allison JJ, Anderson FA, Wyman A, Greenspan SL, LaCroix AZ, Nieves JW, Silverman SL, Siris ES, Watts NB, ... ... Saag KG, et al. Evaluation of a Multi-modal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis: A Randomized Clinical Trial. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 29377378 DOI: 10.1002/Jbmr.3395 |
0.383 |
|
| 2018 |
Roblin DW, Cram P, Lou Y, Edmonds SW, Hall SF, Jones MP, Saag KG, Wright NC, Wolinsky FD. Diet and exercise changes following bone densitometry in the Patient Activation After DXA Result Notification (PAADRN) study. Archives of Osteoporosis. 13: 4. PMID 29307094 DOI: 10.1007/S11657-017-0402-8 |
0.312 |
|
| 2018 |
Curtis JR, Chen R, Li Z, Arora T, Saag KG, Wright NC, Daigle S, Kilgore M, Delzell E. OP0017 The impact of the duration of bisphosphonate drug holidays on hip fracture rates Annals of the Rheumatic Diseases. 77: 58-58. DOI: 10.1136/Annrheumdis-2018-Eular.4953 |
0.375 |
|
| 2018 |
Danila MI, Rahn EJ, Mudano AS, Outman RC, Li P, Redden DT, Anderson FA, Greenspan SL, LaCroix AZ, Nieves JW, Silverman SL, Siris ES, Watts NB, Ladores S, Meneses KM, ... ... Saag KG, et al. THU0472 Factors associated with readiness for adopting osteoporosis treatment change Annals of the Rheumatic Diseases. 77: 445-446. DOI: 10.1136/Annrheumdis-2018-Eular.4802 |
0.373 |
|
| 2018 |
Danila MI, Rahn EJ, Mudano AS, Outman RC, Li P, Redden DT, Anderson FA, Greenspan SL, LaCroix AZ, Nieves JW, Silverman SL, Siris ES, Watts NB, Ladores S, Meneses KM, ... ... Saag KG, et al. THU0490 Temporal increases in side effect concerns of osteoporosis medications among women with previous fractures Annals of the Rheumatic Diseases. 77: 452-452. DOI: 10.1136/Annrheumdis-2018-Eular.4766 |
0.32 |
|
| 2018 |
Saag KG, Pannacciulli N, Geusens P, Adachi JD, Messina OD, Morales-Torres J, Emkey R, Butler PW, Yin X, Lems WF. OP0345 Denosumab compared with risedronate in glucocorticoid-treated subjects: results from the final 24-month analysis of a randomised, double-blind, double-dummy study Annals of the Rheumatic Diseases. 77: 218-218. DOI: 10.1136/Annrheumdis-2018-Eular.1406 |
0.339 |
|
| 2018 |
Saag KG, Miller PD, Cosman F, Fitzpatrick L, Hattersley G, Mitlak B, Bilezikian J, Dore R. Persistent Fracture Reduction with Abaloparatide-SC (TYMLOS™) Followed by 24 Months of Alendronate Journal of Clinical Densitometry. 21: 606-607. DOI: 10.1016/J.Jocd.2018.05.028 |
0.362 |
|
| 2018 |
Saag K, Adler RA. Glucocorticoid‐Induced Osteoporosis Primer On the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 467-473. DOI: 10.1002/9781119266594.Ch59 |
0.337 |
|
| 2017 |
Michael Lewiecki E, Wright NC, Curtis JR, Siris E, Gagel RF, Saag KG, Singer AJ, Steven PM, Adler RA. Hip fracture trends in the United States, 2002 to 2015. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 29282482 DOI: 10.1007/S00198-017-4345-0 |
0.319 |
|
| 2017 |
Wright NC, Saag KG, Dawson-Hughes B, Khosla S, Siris ES. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 28936598 DOI: 10.1007/S00198-017-4207-9 |
0.383 |
|
| 2017 |
Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis. The New England Journal of Medicine. PMID 28892457 DOI: 10.1056/Nejmoa1708322 |
0.38 |
|
| 2017 |
Caplan L, Hansen KE, Saag KG. Response to the ACP Osteoporosis Guideline 2017 Revision. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28881479 DOI: 10.1002/Art.40305 |
0.324 |
|
| 2017 |
Litwic AE, Compston JE, Wyman A, Siris ES, Gehlbach SH, Adachi JD, Chapurlat R, Díez-Pérez A, LaCroix AZ, Nieves JW, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, et al. Self-perception of fracture risk: what can it tell us? Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 28861636 DOI: 10.1007/S00198-017-4200-3 |
0.344 |
|
| 2017 |
Hall SF, Edmonds SW, Lou Y, Cram P, Roblin DW, Saag KG, Wright NC, Jones MP, Wolinsky FD. Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapy. Journal of the American Pharmacists Association : Japha. PMID 28602783 DOI: 10.1016/J.Japh.2017.05.003 |
0.338 |
|
| 2017 |
Wolinsky FD, Lou Y, Edmonds SW, Saag KG, Roblin DW, Wright NC, Jones MP, Cram P. The effects of a patient activation intervention on smoking and excessive drinking cessations: results from the PAADRN randomized controlled trial. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 28573377 DOI: 10.1007/S00198-017-4101-5 |
0.301 |
|
| 2017 |
Cram P, Saag KG, Lou Y, Edmonds SW, Hall SF, Roblin DW, Wright NC, Jones MP, Wolinsky FD. Racial Differences and Disparities in Osteoporosis-related Bone Health: Results From the PAADRN Randomized Controlled Trial. Medical Care. PMID 28288074 DOI: 10.1097/Mlr.0000000000000718 |
0.302 |
|
| 2017 |
Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, ... ... Saag K, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases. PMID 28264816 DOI: 10.1136/Annrheumdis-2016-210715 |
0.321 |
|
| 2016 |
Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG, Shane E. Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 28099754 DOI: 10.1002/Jbmr.3074 |
0.407 |
|
| 2016 |
Wright NC, Saag KG, Dawson-Hughes B, Khosla S, Siris ES. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 27966104 DOI: 10.1007/S00198-016-3865-3 |
0.355 |
|
| 2016 |
Yun H, Xie F, Beyl RN, Chen L, Lewis JD, Saag KG, Curtis JR. The Risk of Hypersensitivity Associated with Biologic Use among Medicare Patients with Rheumatoid Arthritis. Arthritis Care & Research. PMID 27813327 DOI: 10.1002/Acr.23141 |
0.316 |
|
| 2016 |
Curtis JR, Xie F, Mackey D, Gerber N, Bharat A, Beukelman T, Saag KG, Chen L, Nowell B, Ginsberg S. Patient's experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis. Bmc Musculoskeletal Disorders. 17: 405. PMID 27669978 DOI: 10.1186/S12891-016-1254-X |
0.314 |
|
| 2016 |
Wolinsky FD, Lou Y, Edmonds SW, Hall SF, Jones MP, Wright NC, Saag KG, Cram P, Roblin DW. Activating Patients With a Tailored Bone Density Test Results Letter and Educational Brochure: the PAADRN Randomized Controlled Trial. Journal of Clinical Densitometry : the Official Journal of the International Society For Clinical Densitometry. PMID 27647261 DOI: 10.1016/J.Jocd.2016.08.012 |
0.38 |
|
| 2016 |
Houser SH, Au DW, Miller MJ, Chen L, Outman RC, Ray MN, Saag KG, Weech-Maldonado R. Socio-demographic differences in risk information seeking sources for non-steroidal anti-inflammatory drugs (NSAIDS). International Journal of Medical Informatics. 94: 222-7. PMID 27573330 DOI: 10.1016/J.Ijmedinf.2016.07.017 |
0.305 |
|
| 2016 |
Edmonds SW, Cram P, Lou Y, Jones MP, Roblin DW, Saag KG, Wright NC, Wolinsky FD. Effects of a DXA result letter on satisfaction, quality of life, and osteoporosis knowledge: a randomized controlled trial. Bmc Musculoskeletal Disorders. 17: 369. PMID 27562713 DOI: 10.1186/S12891-016-1227-0 |
0.321 |
|
| 2016 |
Coburn BW, Cheetham TC, Rashid N, Chang JM, Levy GD, Kerimian A, Low KJ, Redden DT, Bridges SL, Saag KG, Curtis JR, Mikuls TR. Rationale and design of the randomized evaluation of an ambulatory care pharmacist-led intervention to optimize urate lowering pathways (RAmP-UP) study. Contemporary Clinical Trials. PMID 27449546 DOI: 10.1016/J.Cct.2016.07.019 |
0.302 |
|
| 2016 |
Miller MJ, Weech-Maldonado R, Outman RC, Ray MN, Gary LC, Chen L, Cobaugh DJ, Allison JJ, Saag KG. Evaluating the effectiveness of a patient storytelling DVD intervention to encourage physician-patient communication about nonsteroidal anti-inflammatory drug (NSAID) use. Patient Education and Counseling. PMID 27380647 DOI: 10.1016/J.Pec.2016.06.013 |
0.306 |
|
| 2016 |
Cram P, Wolinsky FD, Lou Y, Edmonds SW, Hall SF, Roblin DW, Wright NC, Jones MP, Saag KG. Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 27363400 DOI: 10.1007/S00198-016-3681-9 |
0.342 |
|
| 2016 |
Balasubramanian A, Wade SW, Adler RA, Lin CJ, Maricic M, O'Malley CD, Saag K, Curtis JR. Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 27273113 DOI: 10.1007/S00198-016-3646-Z |
0.372 |
|
| 2016 |
Saag KG, Agnusdei D, Hans D, Kohlmeier LA, Krohn KD, Leib ES, MacLaughlin EJ, Alam J, Simonelli C, Taylor KA, Marcus R. Trabecular Bone Score in Patients with Chronic Glucocorticoid-Induced Osteoporosis Treated with Alendronate or Teriparatide. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27111239 DOI: 10.1002/Art.39726 |
0.32 |
|
| 2016 |
Compston JE, Wyman A, FitzGerald G, Adachi JD, Chapurlat RD, Cooper C, Díez-Pérez A, Gehlbach SH, Greenspan SL, Hooven FH, LaCroix AZ, March L, Netelenbos JC, Nieves JW, Pfeilschifter J, ... ... Saag KG, et al. Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 26861139 DOI: 10.1002/Jbmr.2810 |
0.333 |
|
| 2016 |
Zhang J, Xie F, Yun H, Chen L, Muntner P, Levitan EB, Safford MM, Kent ST, Osterman MT, Lewis JD, Saag K, Singh JA, Curtis JR. Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. PMID 26792814 DOI: 10.1136/Annrheumdis-2015-207870 |
0.326 |
|
| 2016 |
Cooper C, Bardin T, Brandi ML, Cacoub P, Caminis J, Civitelli R, Cutolo M, Dere W, Devogelaer JP, Diez-Perez A, Einhorn TA, Emonts P, Ethgen O, Kanis JA, Kaufman JM, ... ... Saag K, et al. Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Aging Clinical and Experimental Research. 28: 1-16. PMID 26746234 DOI: 10.1007/S40520-015-0522-1 |
0.318 |
|
| 2016 |
Whittier X, Saag KG. Glucocorticoid-induced Osteoporosis. Rheumatic Diseases Clinics of North America. 42: 177-189. PMID 26611558 DOI: 10.1016/J.Rdc.2015.08.005 |
0.354 |
|
| 2016 |
Saag KG, Alexandersen P, Benhamou C, Gilchrist N, Halse J, Michael LE, Lippuner K, McClung M, Shiraki M, DaSilva CA, Verbruggen N, Scott BB, Lombardi A. Efficacy of odanacatib in postmenopausal women with osteoporosis: subgroup analyses of data from the phase 3 long-term odanacatib fracture trial (LOFT) Bone Abstracts. DOI: 10.1530/Boneabs.5.Oc1.1 |
0.326 |
|
| 2015 |
Mullen MB, Saag KG. Evaluating and mitigating fracture risk in established rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology. 29: 614-27. PMID 26697770 DOI: 10.1016/J.Berh.2015.09.005 |
0.408 |
|
| 2015 |
Warriner AH, Outman RC, Allison JJ, Curtis JR, Markward NJ, Redden DT, Safford MM, Stanek EJ, Steinkellner AR, Saag KG. An Internet-based Controlled Trial Aimed to Improve Osteoporosis Prevention among Chronic Glucocorticoid Users. The Journal of Rheumatology. 42: 1478-83. PMID 26136484 DOI: 10.3899/Jrheum.141238 |
0.306 |
|
| 2015 |
Yun H, Xie F, Delzell E, Chen L, Yang S, Saag KG, Joseph G, Harrison D, Curtis JR. The Comparative Effectiveness of Biologics among Older Adults and Disabled Rheumatoid Arthritis Patients in the Medicare Population. British Journal of Clinical Pharmacology. PMID 26130274 DOI: 10.1111/Bcp.12709 |
0.311 |
|
| 2015 |
Lems WF, Saag K. Bisphosphonates and glucocorticoid-induced osteoporosis: cons Endocrine. 49: 628-634. PMID 26041376 DOI: 10.1007/S12020-015-0639-1 |
0.381 |
|
| 2015 |
Boers M, Buttgereit F, Saag K, Alten R, Grahn A, Storey D, Rice P, Kirwan J. What is the relationship between morning symptoms and measures of disease activity in patients with rheumatoid arthritis? Arthritis Care & Research. PMID 25807939 DOI: 10.1002/Acr.22592 |
0.3 |
|
| 2015 |
Curtis JR, Xie F, Yun H, Saag KG, Chen L, Delzell E. Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab. Arthritis & Rheumatology (Hoboken, N.J.). 67: 1456-64. PMID 25708920 DOI: 10.1002/Art.39075 |
0.301 |
|
| 2015 |
Rashid N, Coburn BW, Wu YL, Cheetham TC, Curtis JR, Saag KG, Mikuls TR. Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system. The Journal of Rheumatology. 42: 504-12. PMID 25512479 DOI: 10.3899/Jrheum.140588 |
0.345 |
|
| 2015 |
Zhang J, Xie F, Delzell E, Yun H, Lewis JD, Haynes K, Chen L, Beukelman T, Saag KG, Curtis JR. Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients. Arthritis Care & Research. 67: 624-32. PMID 25370912 DOI: 10.1002/Acr.22510 |
0.311 |
|
| 2015 |
Silverman S, Curtis J, Saag K, Flahive J, Adachi J, Anderson F, Chapurlat R, Cooper C, Diez-Perez A, Greenspan S, Hooven F, Le Croix A, March L, Netelenbos JC, Nieves J, et al. International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 26: 419-20. PMID 25257932 DOI: 10.1007/S00198-014-2883-2 |
0.322 |
|
| 2015 |
Yun H, Xie F, Delzell E, Chen L, Levitan EB, Lewis JD, Saag KG, Beukelman T, Winthrop K, Baddley JW, Curtis JR. Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy. Arthritis Care & Research. 67: 731-6. PMID 25201241 DOI: 10.1002/Acr.22470 |
0.328 |
|
| 2015 |
Yun H, Xie F, Delzell E, Chen L, Levitan EB, Lewis JD, Saag KG, Beukelman T, Winthrop K, Baddley JW, Curtis JR. Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy. Annals of the Rheumatic Diseases. 74: 1065-71. PMID 24608404 DOI: 10.1136/Annrheumdis-2013-204011 |
0.304 |
|
| 2014 |
Edmonds SW, Cram P, Lu X, Roblin DW, Wright NC, Saag KG, Solimeo SL. Improving bone mineral density reporting to patients with an illustration of personal fracture risk. Bmc Medical Informatics and Decision Making. 14: 101. PMID 25743200 DOI: 10.1186/S12911-014-0101-Y |
0.38 |
|
| 2014 |
Safford MM, Barasch A, Curtis JR, Outman R, Saag K. Bisphosphonates and hip and nontraumatic subtrochanteric femoral fractures in the Veterans Health Administration. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 20: 357-62. PMID 25275761 DOI: 10.1097/Rhu.0000000000000170 |
0.363 |
|
| 2014 |
Sattui SE, Saag KG. Fracture mortality: associations with epidemiology and osteoporosis treatment Nature Reviews Endocrinology. 10: 592-602. PMID 25091729 DOI: 10.1038/Nrendo.2014.125 |
0.334 |
|
| 2014 |
Warriner AH, Outman RC, Feldstein AC, Roblin DW, Allison JJ, Curtis JR, Redden DT, Rix MM, Robinson BE, Rosales AG, Safford MM, Saag KG. Effect of self-referral on bone mineral density testing and osteoporosis treatment. Medical Care. 52: 743-50. PMID 24984211 DOI: 10.1097/Mlr.0000000000000170 |
0.31 |
|
| 2014 |
Edmonds SW, Solimeo SL, Lu X, Roblin DW, Saag KG, Cram P. Developing a bone mineral density test result letter to send to patients: a mixed-methods study. Patient Preference and Adherence. 8: 827-41. PMID 24940049 DOI: 10.2147/Ppa.S60106 |
0.318 |
|
| 2014 |
Miller MJ, Allison JJ, Cobaugh DJ, Ray MN, Saag KG. A group-randomized trial of shared decision making for non-steroidal anti-inflammatory drug risk awareness: primary results and lessons learned. Journal of Evaluation in Clinical Practice. 20: 638-48. PMID 24916786 DOI: 10.1111/Jep.12193 |
0.326 |
|
| 2014 |
Saag KG. Bone safety of low-dose glucocorticoids in rheumatic diseases. Annals of the New York Academy of Sciences. 1318: 55-64. PMID 24815076 DOI: 10.1111/Nyas.12446 |
0.372 |
|
| 2014 |
Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Hughes B. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 29: 2520-6. PMID 24771492 DOI: 10.1002/Jbmr.2269 |
0.304 |
|
| 2014 |
Yun H, Curtis JR, Guo L, Kilgore M, Muntner P, Saag K, Matthews R, Morrisey M, Wright NC, Becker DJ, Delzell E. Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries. Bmc Musculoskeletal Disorders. 15: 112. PMID 24684864 DOI: 10.1186/1471-2474-15-112 |
0.343 |
|
| 2014 |
Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ, Harris ST, Jan de Beur SM, Khosla S, Lane NE, Lindsay R, Nana AD, Orwoll ES, Saag K, Silverman S, et al. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 25: 1439-43. PMID 24577348 DOI: 10.1007/S00198-014-2655-Z |
0.361 |
|
| 2014 |
FitzGerald G, Compston JE, Chapurlat RD, Pfeilschifter J, Cooper C, Hosmer DW, Adachi JD, Anderson FA, Díez-Pérez A, Greenspan SL, Netelenbos JC, Nieves JW, Rossini M, Watts NB, Hooven FH, ... ... Saag KG, et al. Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW). The Journal of Clinical Endocrinology and Metabolism. 99: 817-26. PMID 24423345 DOI: 10.1210/Jc.2013-3468 |
0.324 |
|
| 2014 |
Becker DJ, Arora T, Kilgore ML, Curtis JR, Delzell E, Saag KG, Yun H, Morrisey MA. Trends in the utilization and outcomes of Medicare patients hospitalized for hip fracture, 2000-2008. Journal of Aging and Health. 26: 360-79. PMID 24401322 DOI: 10.1177/0898264313516994 |
0.347 |
|
| 2014 |
Curtis JR, Wright NC, Xie F, Chen L, Zhang J, Saag KG, Bharat A, Kremer J, Cofield S, Winthrop K, Delzell E. Use of health plan combined with registry data to predict clinical trial recruitment. Clinical Trials (London, England). 11: 96-101. PMID 24346611 DOI: 10.1177/1740774513512185 |
0.352 |
|
| 2014 |
Compston JE, Flahive J, Hooven FH, Anderson FA, Adachi JD, Boonen S, Chapurlat RD, Cooper C, Díez-Perez A, Greenspan SL, LaCroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, ... Saag KG, et al. Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW). Calcified Tissue International. 94: 223-31. PMID 24077896 DOI: 10.1007/S00223-013-9801-Z |
0.335 |
|
| 2014 |
Zhang J, Delzell E, Curtis JR, Hooven F, Gehlbach SH, Anderson FA, Saag KG. Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 25: 317-24. PMID 23982799 DOI: 10.1007/S00198-013-2444-0 |
0.351 |
|
| 2014 |
Gregson CL, Dennison EM, Compston JE, Adami S, Adachi JD, Anderson FA, Boonen S, Chapurlat R, Díez-Pérez A, Greenspan SL, Hooven FH, LaCroix AZ, Nieves JW, Netelenbos JC, Pfeilschifter J, ... ... Saag KG, et al. Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 25: 85-95. PMID 23884437 DOI: 10.1007/S00198-013-2438-Y |
0.352 |
|
| 2014 |
Tajeu GS, Delzell E, Smith W, Arora T, Curtis JR, Saag KG, Morrisey MA, Yun H, Kilgore ML. Death, debility, and destitution following hip fracture. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 69: 346-53. PMID 23873945 DOI: 10.1093/Gerona/Glt105 |
0.353 |
|
| 2014 |
Compston JE, Flahive J, Hosmer DW, Watts NB, Siris ES, Silverman S, Saag KG, Roux C, Rossini M, Pfeilschifter J, Nieves JW, Netelenbos JC, March L, LaCroix AZ, Hooven FH, et al. Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 29: 487-93. PMID 23873741 DOI: 10.1002/Jbmr.2051 |
0.349 |
|
| 2014 |
Díez-Pérez A, Adachi JD, Adami S, Anderson FA, Boonen S, Chapurlat R, Compston JE, Cooper C, Gehlbach SH, Greenspan SL, Hooven FH, LaCroix AZ, Nieves JW, Netelenbos JC, Pfeilschifter J, ... ... Saag KG, et al. Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW). Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 29: 260-7. PMID 23794198 DOI: 10.1002/Jbmr.2023 |
0.39 |
|
| 2014 |
Harrold L, Etzel C, Gibofsky A, Kremer J, Pillinger M, Saag K, Schlesinger N, Terkeltaub R, Cox V, Greenberg J. OP0136 Sex Differences in Gout Characteristics: Tailoring Care for Women and Men Annals of the Rheumatic Diseases. 73: 112.1-112. DOI: 10.1136/Annrheumdis-2014-Eular.2486 |
0.343 |
|
| 2013 |
Warriner AH, Saag KG. Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids. Current Opinion in Endocrinology, Diabetes and Obesity. 20: 510-516. PMID 24468753 DOI: 10.1097/01.Med.0000436249.84273.7B |
0.338 |
|
| 2013 |
Costa AG, Wyman A, Siris ES, Watts NB, Silverman S, Saag KG, Roux C, Rossini M, Pfeilschifter J, Nieves JW, Netelenbos JC, March L, LaCroix AZ, Hooven FH, Greenspan SL, et al. When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Plos One. 8: e83306. PMID 24349484 DOI: 10.1371/Journal.Pone.0083306 |
0.335 |
|
| 2013 |
Zhang J, Morgan SL, Saag KG. Osteopenia: debates and dilemmas. Current Rheumatology Reports. 15: 384. PMID 24222198 DOI: 10.1007/S11926-013-0384-5 |
0.366 |
|
| 2013 |
Warriner AH, Saag KG. Prevention and Treatment of Bone Changes Associated with Exposure to Glucocorticoids Current Osteoporosis Reports. 11: 341-347. PMID 24097304 DOI: 10.1007/S11914-013-0173-0 |
0.4 |
|
| 2013 |
Saag KG, Curtis J, Warriner A. Challenges in defining quality of care for glucocorticoid-induced osteoporosis: defending good against perfect. The Journal of Rheumatology. 40: 1640-2. PMID 24085752 DOI: 10.3899/Jrheum.130980 |
0.413 |
|
| 2013 |
Solomon DH, Curtis JR, Saag KG, Lii J, Chen L, Harrold LR, Herrinton LJ, Graham DJ, Kowal MK, Kuriya B, Liu L, Griffin MR, Lewis JD, Rassen JA. Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs. The American Journal of Medicine. 126: 730.e9-730.e17. PMID 23885678 DOI: 10.1016/J.Amjmed.2013.02.016 |
0.311 |
|
| 2013 |
Zhang J, Xie F, Delzell E, Chen L, Kilgore ML, Yun H, Saag KG, Lewis JD, Curtis JR. Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program. Arthritis Care & Research. 65: 1743-51. PMID 23754804 DOI: 10.1002/Acr.22055 |
0.305 |
|
| 2013 |
Warriner AH, Saag KG. Osteoporosis diagnosis and medical treatment. Orthopedic Clinics of North America. 44: 125-135. PMID 23544819 DOI: 10.1016/J.Ocl.2013.01.005 |
0.364 |
|
| 2013 |
Kilgore ML, Outman R, Locher JL, Allison JJ, Mudano A, Kitchin B, Saag KG, Curtis JR. Multimodal intervention to improve osteoporosis care in home health settings: results from a cluster randomized trial. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 24: 2555-60. PMID 23536256 DOI: 10.1007/S00198-013-2340-7 |
0.31 |
|
| 2013 |
Yazdany J, Schmajuk G, Robbins M, Daikh D, Beall A, Yelin E, Barton J, Carlson A, Margaretten M, Zell J, Gensler LS, Kelly V, Saag K, King C. Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question. Arthritis Care & Research. 65: 329-39. PMID 23436818 DOI: 10.1002/Acr.21930 |
0.308 |
|
| 2013 |
Yun H, Curtis JR, Saag K, Kilgore M, Muntner P, Smith W, Matthews R, Wright N, Morrisey MA, Delzell E. Generic alendronate use among Medicare beneficiaries: are Part D data complete? Pharmacoepidemiology and Drug Safety. 22: 55-63. PMID 23135758 DOI: 10.1002/Pds.3361 |
0.303 |
|
| 2013 |
Ward MA, Xu Y, Viswanathan HN, Stolshek BS, Clay B, Adams JL, Kallich JD, Fine S, Saag KG. Association between osteoporosis treatment change and adherence, incident fracture, and total healthcare costs in a Medicare Advantage Prescription Drug plan. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 24: 1195-206. PMID 23100119 DOI: 10.1007/S00198-012-2140-5 |
0.336 |
|
| 2013 |
Edmonds SW, Wolinsky FD, Christensen AJ, Lu X, Jones MP, Roblin DW, Saag KG, Cram P. The PAADRN study: a design for a randomized controlled practical clinical trial to improve bone health. Contemporary Clinical Trials. 34: 90-100. PMID 23085132 DOI: 10.1016/J.Cct.2012.10.002 |
0.327 |
|
| 2013 |
Kilgore ML, Curtis JR, Delzell E, Becker DJ, Arora T, Saag KG, Morrisey MA. A close examination of healthcare expenditures related to fractures. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 816-20. PMID 23074090 DOI: 10.1002/Jbmr.1789 |
0.332 |
|
| 2013 |
Buttgereit F, Mehta D, Kirwan J, Szechinski J, Boers M, Alten RE, Supronik J, Szombati I, Romer U, Witte S, Saag KG. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2) Annals of the Rheumatic Diseases. 72: 204-210. PMID 22562974 DOI: 10.1136/Annrheumdis-2011-201067 |
0.325 |
|
| 2013 |
Curtis JR, Sharma P, Arora T, Bharat A, Barnes I, Morrisey MA, Kilgore M, Saag KG, Wright NC, Yun HG, Delzell E. Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting System. Arthritis Care & Research. 65: 235-43. PMID 22556118 DOI: 10.1002/Acr.21713 |
0.33 |
|
| 2013 |
Ioannidis G, Flahive J, Pickard L, Papaioannou A, Chapurlat RD, Saag KG, Silverman S, Anderson FA, Gehlbach SH, Hooven FH, Boonen S, Compston JE, Cooper C, Díez-Perez A, Greenspan SL, et al. Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 24: 59-67. PMID 22525976 DOI: 10.1007/S00198-012-1968-Z |
0.338 |
|
| 2013 |
Xu Y, Viswanathan HN, Ward MA, Clay B, Adams JL, Stolshek BS, Kallich JD, Fine S, Saag KG. Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug members in a national health plan. Journal of Evaluation in Clinical Practice. 19: 50-9. PMID 21914091 DOI: 10.1111/J.1365-2753.2011.01766.X |
0.313 |
|
| 2013 |
Robinson B, Roblin D, Saag K, Wolinsky F, Cram P. PS3-45: A Randomized Controlled Trial to Improve Bone Health: A Multi-Modal Approach to Patient Recruitment Clinical Medicine & Research. 11: 141-141. DOI: 10.3121/Cmr.2013.1176.Ps3-45 |
0.312 |
|
| 2013 |
Gregson C, Dennison E, Compston J, Adami S, Adachi J, Anderson F, Boonen S, Chapurlat R, Diez-Perez A, Greenspan S, Hooven F, Lacroix A, Nieves J, Netelenbos JC, Pfeilschifter J, ... ... Saag K, et al. Disease-specific perception of fracture risk and incident fracture rates among postmenopausal women: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Bone Abstracts. DOI: 10.1530/Boneabs.01.Oc1.1 |
0.346 |
|
| 2013 |
Curtis JR, Zhang J, Xie F, Delzell ES, Chen L, Kilgore M, Yun H, Saag KG, Lewis J. FRI0531 Biologic and dmard combination and monotherapy among medicare beneficiaries with rheumatoid arthritis Annals of the Rheumatic Diseases. 72: A554.2-A554. DOI: 10.1136/Annrheumdis-2013-Eular.1658 |
0.31 |
|
| 2013 |
Yun H, Xie F, Delzell E, Chen L, Levitan E, Lewis J, Saag KG, Beukelman T, Winthrop KL, Baddley JW, Muntner P, Curtis JR. FRI0529 Comparative risks for serious infections associated with biologics in high risk rheumatoid arthritis patients Annals of the Rheumatic Diseases. 72: A553.3-A554. DOI: 10.1136/Annrheumdis-2013-Eular.1656 |
0.314 |
|
| 2013 |
Furst D, Winthrop KL, Alexander KA, Vashishtha A, Francom SF, Saag KG. FRI0223 Long-term targeted safety event rates in ra patients following initiation of rituximab: interim analysis from sunstone registry Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.1350 |
0.304 |
|
| 2013 |
Curtis JR, Yang S, Patkar N, Chen L, Singh J, Cannon G, Mikuls T, Delzell E, Saag KG, Safford MM, Duvall S, Alexander K, Napalkov P, Kamauu A, Baddley J. FRI0149 Comparative risk for hospitalized bacterial infections amoung us veterans with rheumatoid arthritis switching from anti-TNF therapy Annals of the Rheumatic Diseases. 71: 361-361. DOI: 10.1136/Annrheumdis-2012-Eular.2606 |
0.329 |
|
| 2012 |
Warriner AH, Outman RC, Kitchin E, Chen L, Morgan S, Saag KG, Curtis JR. A randomized trial of a mailed intervention and self-scheduling to improve osteoporosis screening in postmenopausal women. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 2603-10. PMID 22836812 DOI: 10.1002/Jbmr.1720 |
0.34 |
|
| 2012 |
Curtis JR, Xie F, Chen L, Muntner P, Grijalva CG, Spettell C, Fernandes J, McMahan RM, Baddley JW, Saag KG, Beukelman T, Delzell E. Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients. Arthritis Care & Research. 64: 1480-9. PMID 22833479 DOI: 10.1002/Acr.21805 |
0.331 |
|
| 2012 |
Curtis JR, Yun H, Lange JL, Matthews R, Sharma P, Saag KG, Delzell E. Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data. Arthritis Care & Research. 64: 1855-63. PMID 22730364 DOI: 10.1002/Acr.21759 |
0.371 |
|
| 2012 |
Wright NC, Saag KG, Curtis JR, Smith WK, Kilgore ML, Morrisey MA, Yun H, Zhang J, Delzell ES. Recent trends in hip fracture rates by race/ethnicity among older US adults. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 2325-32. PMID 22692958 DOI: 10.1002/Jbmr.1684 |
0.338 |
|
| 2012 |
Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, ... ... Saag KG, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care & Research. 64: 625-39. PMID 22473917 DOI: 10.1002/Acr.21641 |
0.332 |
|
| 2012 |
Wright NC, Saag KG. From Fracture Risk Prediction to Evaluating Fracture Patterns: Recent Advances in the Epidemiology of Osteoporosis Current Rheumatology Reports. 14: 205-211. PMID 22453874 DOI: 10.1007/S11926-012-0251-9 |
0.338 |
|
| 2012 |
Dennison EM, Compston JE, Flahive J, Siris ES, Gehlbach SH, Adachi JD, Boonen S, Chapurlat R, Díez-Pérez A, Anderson FA, Hooven FH, LaCroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, ... ... Saag KG, et al. Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone. 50: 1288-93. PMID 22426498 DOI: 10.1016/J.Bone.2012.02.639 |
0.344 |
|
| 2012 |
Roux C, Wyman A, Hooven FH, Gehlbach SH, Adachi JD, Chapurlat RD, Compston JE, Cooper C, Díez-Pérez A, Greenspan SL, Lacroix AZ, Netelenbos JC, Pfeilschifter J, Rossini M, Saag KG, et al. Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 23: 2863-71. PMID 22398855 DOI: 10.1007/S00198-012-1935-8 |
0.338 |
|
| 2012 |
Gaffo AL, Saag KG. Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet? American Journal of Cardiovascular Drugs. 12: 1-6. PMID 22204636 DOI: 10.2165/11594580-000000000-00000 |
0.307 |
|
| 2012 |
Teng GG, Ang L, Saag KG, Yu MC, Yuan J, Koh W. Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study Annals of the Rheumatic Diseases. 71: 924-928. PMID 22172492 DOI: 10.1136/Ard.2011.200523 |
0.309 |
|
| 2012 |
Hadji P, Zanchetta JR, Russo L, Recknor CP, Saag KG, McKiernan FE, Silverman SL, Alam J, Burge RT, Krege JH, Lakshmanan MC, Masica DN, Mitlak BH, Stock JL. The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporosis International. 23: 2141-2150. PMID 22159672 DOI: 10.1007/S00198-011-1856-Y |
0.34 |
|
| 2012 |
Gehlbach S, Saag KG, Adachi JD, Hooven FH, Flahive J, Boonen S, Chapurlat RD, Compston JE, Cooper C, Díez-Perez A, Greenspan SL, LaCroix AZ, Netelenbos JC, Pfeilschifter J, Rossini M, et al. Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 645-53. PMID 22113888 DOI: 10.1002/Jbmr.1476 |
0.344 |
|
| 2012 |
Narongroeknawin P, Patkar NM, Shakoory B, Jain A, Curtis JR, Delzell E, Lander PH, Lopez-Ben RR, Pitt MJ, Safford MM, Volgas DA, Saag KG. Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data. Journal of Clinical Densitometry : the Official Journal of the International Society For Clinical Densitometry. 15: 92-102. PMID 22071028 DOI: 10.1016/J.Jocd.2011.09.001 |
0.327 |
|
| 2012 |
Sambrook PN, Roux C, Devogelaer JP, Saag K, Lau CS, Reginster JY, Bucci-Rechtweg C, Su G, Reid DM. Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate. Bone. 50: 289-95. PMID 22061864 DOI: 10.1016/J.Bone.2011.10.024 |
0.312 |
|
| 2012 |
Outman RC, Curtis JR, Locher JL, Allison JJ, Saag KG, Kilgore ML. Improving osteoporosis care in high-risk home health patients through a high-intensity intervention. Contemporary Clinical Trials. 33: 206-12. PMID 22005175 DOI: 10.1016/J.Cct.2011.09.020 |
0.333 |
|
| 2012 |
Roux C, Reid DM, Devogelaer JP, Saag K, Lau CS, Reginster JY, Papanastasiou P, Bucci-Rechtweg C, Su G, Sambrook PN. Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 23: 1083-90. PMID 21975559 DOI: 10.1007/S00198-011-1800-1 |
0.361 |
|
| 2012 |
Sambrook PN, Roux C, Devogelaer J, Saag K, Lau C, Reginster J, Bucci-Rechtweg C, Su G, Reid DM. Corrigendum to "Bisphosphonates and glucocorticoid osteoporosis in men: Results of a randomized controlled trial comparing zoledronic acid with risedronate" [Bone 50 (2012) 289-295] Bone. 50: 811. DOI: 10.1016/J.Bone.2011.12.006 |
0.31 |
|
| 2011 |
Zhang J, Saag KG, Curtis JR. Long-term Safety Concerns of Antiresorptive Therapy Rheumatic Diseases Clinics of North America. 37: 387-400. PMID 22023898 DOI: 10.1016/J.Rdc.2011.08.001 |
0.345 |
|
| 2011 |
Compston JE, Watts NB, Chapurlat R, Cooper C, Boonen S, Greenspan S, Pfeilschifter J, Silverman S, Díez-Pérez A, Lindsay R, Saag KG, Netelenbos JC, Gehlbach S, Hooven FH, Flahive J, et al. Obesity is not protective against fracture in postmenopausal women: GLOW. The American Journal of Medicine. 124: 1043-50. PMID 22017783 DOI: 10.1016/J.Amjmed.2011.06.013 |
0.304 |
|
| 2011 |
Sambrook PN, Flahive J, Hooven FH, Boonen S, Chapurlat R, Lindsay R, Nguyen TV, Díez-Perez A, Pfeilschifter J, Greenspan SL, Hosmer D, Netelenbos JC, Adachi JD, Watts NB, Cooper C, ... ... Saag KG, et al. Predicting fractures in an international cohort using risk factor algorithms without BMD. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 2770-7. PMID 21887705 DOI: 10.1002/Jbmr.503 |
0.37 |
|
| 2011 |
Adler RA, Bates DW, Dell RM, LeBoff MS, Majumdar SR, Saag KG, Solomon DH, Suarez-Almazor ME. Systems-based approaches to osteoporosis and fracture care: policy and research recommendations from the workgroups. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 22: 495-500. PMID 21847772 DOI: 10.1007/S00198-011-1708-9 |
0.314 |
|
| 2011 |
Leib ES, Saag KG, Adachi JD, Geusens PP, Binkley N, McCloskey EV, Hans DB. Official Positions for FRAX® Clinical Regarding Glucocorticoids: The Impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture: From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX® Journal of Clinical Densitometry. 14: 212-219. PMID 21810527 DOI: 10.1016/J.Jocd.2011.05.014 |
0.352 |
|
| 2011 |
Díez-Pérez A, Hooven FH, Adachi JD, Adami S, Anderson FA, Boonen S, Chapurlat R, Compston JE, Cooper C, Delmas P, Greenspan SL, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, ... ... Saag KG, et al. Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone. 49: 493-8. PMID 21605715 DOI: 10.1016/J.Bone.2011.05.007 |
0.301 |
|
| 2011 |
Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care & Research. 63: 465-82. PMID 21452260 DOI: 10.1002/Acr.20460 |
0.309 |
|
| 2011 |
Teitelbaum SL, Seton MP, Saag KG. Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis? Arthritis and Rheumatism. 63: 325-8. PMID 21279986 DOI: 10.1002/Art.30135 |
0.362 |
|
| 2011 |
Warriner AH, Patkar NM, Curtis JR, Delzell E, Gary L, Kilgore M, Saag K. Which fractures are most attributable to osteoporosis? Journal of Clinical Epidemiology. 64: 46-53. PMID 21130353 DOI: 10.1016/J.Jclinepi.2010.07.007 |
0.32 |
|
| 2011 |
Schmitt MR, Miller MJ, Harrison DL, Farmer KC, Allison JJ, Cobaugh DJ, Saag KG. Communicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients' risk awareness. Patient Education and Counseling. 83: 391-7. PMID 21129892 DOI: 10.1016/J.Pec.2010.10.032 |
0.309 |
|
| 2011 |
Taylor AJ, Gary LC, Arora T, Becker DJ, Curtis JR, Kilgore ML, Morrisey MA, Saag KG, Matthews R, Yun H, Smith W, Delzell E. Clinical and demographic factors associated with fractures among older Americans. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 22: 1263-74. PMID 20559818 DOI: 10.1007/S00198-010-1300-8 |
0.329 |
|
| 2011 |
Caplan L, Hines AE, Williams E, Prochazka AV, Saag KG, Cunningham F, Hutt E. An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 22: 305-15. PMID 20358362 DOI: 10.1007/S00198-010-1201-X |
0.366 |
|
| 2011 |
Siris ES, Gehlbach S, Adachi JD, Boonen S, Chapurlat RD, Compston JE, Cooper C, Delmas P, Díez-Pérez A, Hooven FH, Lacroix AZ, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, ... Saag KG, et al. Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 22: 27-35. PMID 20358360 DOI: 10.1007/S00198-010-1211-8 |
0.349 |
|
| 2011 |
Hadji P, Zanchetta JR, Russo LA, Recknor CP, Saag KG, McKiernan FE, Silverman SL, Alam J, Burge RT, Krege JH, Lakshmanan ML, Masica DN, Mitlak BH, Stock JL. Effect of teriparatide compared with risedronate on back pain and incident vertebral fractures in postmenopausal women with osteoporotic vertebral fractures Bone. 48. DOI: 10.1016/J.Bone.2011.03.108 |
0.326 |
|
| 2010 |
Hayes BL, Curtis JR, Laster A, Saag K, Tanner SB, Liu C, Womack C, Johnson KC, Khaliq F, Carbone LD. Osteoporosis care in the United States after declines in reimbursements for DXA. Journal of Clinical Densitometry : the Official Journal of the International Society For Clinical Densitometry. 13: 352-60. PMID 21029972 DOI: 10.1016/J.Jocd.2010.08.001 |
0.311 |
|
| 2010 |
Curtis JR, Arora T, Matthews RS, Taylor A, Becker DJ, Colon-Emeric C, Kilgore ML, Morrisey MA, Saag KG, Safford MM, Warriner A, Delzell E. Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. Journal of the American Medical Directors Association. 11: 584-91. PMID 20889095 DOI: 10.1016/J.Jamda.2009.12.004 |
0.372 |
|
| 2010 |
Schett G, Saag KG, Bijlsma JWJ. From bone biology to clinical outcome: state of the art and future perspectives Annals of the Rheumatic Diseases. 69: 1415-1419. PMID 20650876 DOI: 10.1136/Ard.2010.135061 |
0.308 |
|
| 2010 |
Adachi JD, Adami S, Gehlbach S, Anderson FA, Boonen S, Chapurlat RD, Compston JE, Cooper C, Delmas P, Díez-Pérez A, Greenspan SL, Hooven FH, LaCroix AZ, Lindsay R, Netelenbos JC, ... ... Saag KG, et al. Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. Mayo Clinic Proceedings. 85: 806-13. PMID 20634496 DOI: 10.4065/Mcp.2010.0082 |
0.355 |
|
| 2010 |
Miller MJ, Allison JJ, Schmitt MR, Ray MN, Funkhouser EM, Cobaugh DJ, Saag KG, LaCivita C. Using single-item health literacy screening questions to identify patients who read written nonsteroidal anti-inflammatory medicine information provided at pharmacies. Journal of Health Communication. 15: 413-27. PMID 20574879 DOI: 10.1080/10810731003753091 |
0.302 |
|
| 2010 |
Becker DJ, Yun H, Kilgore ML, Curtis JR, Delzell E, Gary LC, Saag KG, Morrisey MA. Health services utilization after fractures: evidence from Medicare. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 65: 1012-20. PMID 20530242 DOI: 10.1093/Gerona/Glq093 |
0.351 |
|
| 2010 |
Miller MJ, Schmitt MR, Allison JJ, Cobaugh DJ, Ray MN, Saag KG. The role of health literacy and written medicine information in nonsteroidal antiinflammatory drug risk awareness. The Annals of Pharmacotherapy. 44: 274-84. PMID 20103612 DOI: 10.1345/Aph.1M479 |
0.301 |
|
| 2010 |
Eastell R, Chen P, Saag KG, Burshell AL, Wong M, Warner MR, Krege JH. Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate. Bone. 46: 929-34. PMID 20060078 DOI: 10.1016/J.Bone.2009.12.021 |
0.341 |
|
| 2010 |
Beukelman T, Saag KG, Curtis JR, Kilgore ML, Pisu M. Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis Osteoporosis International. 21: 1573-1584. PMID 19937227 DOI: 10.1007/S00198-009-1114-8 |
0.364 |
|
| 2010 |
Roux C, Reid DM, Devogelaer J, Saag K, Lau C, Reginster J, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrink P, Sambrook PN. Effect of Single Annual Infusion of Zoledronic Acid (5 Mg) on Lumbar Spine Bone Mineral Density versus Daily Oral Risedronate (5 Mg) in Subgroups of Patients Receiving Glucocorticoid Therapy Journal of Clinical Densitometry. 13: 133. DOI: 10.1016/J.Jocd.2010.01.088 |
0.303 |
|
| 2010 |
Gehlbach S, Saag KG, Flahive J, Anderson FA, Hooven F. Previous fractures increase risk for subsequent fractures at multiple sites: global longitudinal study of osteoporosis in women Bone. 47. DOI: 10.1016/J.Bone.2010.04.422 |
0.343 |
|
| 2010 |
Greenspan S, Gehlbach S, Boonen S, Chapurlat RD, Cooper C, Lacroix A, Sambrook PN, FitzGerald G, Saag KG, Hooven F. Management of incident fractures in an international cohort study. Global longitudinal study of osteoporosis in women Bone. 47. DOI: 10.1016/J.Bone.2010.04.420 |
0.331 |
|
| 2010 |
Taylor AJ, Gary LC, Arora T, Becker DJ, Curtis JR, Kilgore ML, Morrisey MA, Saag KG, Matthews R, Yun H, Smith W, Delzell E. Erratum to: Clinical and demographic factors associated with fractures among older Americans Osteoporosis International. 22: 1275-1276. DOI: 10.1007/S00198-010-1347-6 |
0.316 |
|
| 2009 |
Saag KG, Zanchetta JR, Devogelaer JP, Adler RA, Eastell R, See K, Krege JH, Krohn K, Warner MR. Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial. Arthritis and Rheumatism. 60: 3346-55. PMID 19877063 DOI: 10.1002/Art.24879 |
0.337 |
|
| 2009 |
Saag KG, Geusens P. Progress in osteoporosis and fracture prevention: focus on postmenopausal women Arthritis Research & Therapy. 11: 251-251. PMID 19849819 DOI: 10.1186/Ar2815 |
0.392 |
|
| 2009 |
Watts NB, Lewiecki EM, Bonnick SL, Laster AJ, Binkley N, Blank RD, Geusens PP, Miller PD, Petak SM, Recker RR, Saag KG, Schousboe J, Siris ES, Bilezikian JP. Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis. Journal of Bone and Mineral Research. 24: 1643-1646. PMID 19712042 DOI: 10.1359/Jbmr.090818 |
0.315 |
|
| 2009 |
Curtis JR, McClure LA, Delzell E, Howard VJ, Orwoll E, Saag KG, Safford M, Howard G. Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. Journal of General Internal Medicine. 24: 956-62. PMID 19551449 DOI: 10.1007/S11606-009-1031-8 |
0.342 |
|
| 2009 |
Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N, Giezek H, West J, Schnitzer TJ. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial. The Journal of Rheumatology. 36: 1705-14. PMID 19487264 DOI: 10.3899/Jrheum.081207 |
0.36 |
|
| 2009 |
Hooven FH, Adachi JD, Adami S, Boonen S, Compston J, Cooper C, Delmas P, Diez-Perez A, Gehlbach S, Greenspan SL, LaCroix A, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, ... Saag KG, et al. The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 20: 1107-16. PMID 19468663 DOI: 10.1007/S00198-009-0958-2 |
0.334 |
|
| 2009 |
Kilgore ML, Morrisey MA, Becker DJ, Gary LC, Curtis JR, Saag KG, Yun H, Matthews R, Smith W, Taylor A, Arora T, Delzell E. Health care expenditures associated with skeletal fractures among Medicare beneficiaries, 1999-2005. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 24: 2050-5. PMID 19453260 DOI: 10.1359/Jbmr.090523 |
0.339 |
|
| 2009 |
Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrink P, Sambrook PN. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet (London, England). 373: 1253-63. PMID 19362675 DOI: 10.1016/S0140-6736(09)60250-6 |
0.379 |
|
| 2009 |
Warriner AH, Outman RC, Saag KG, Berry SD, Colón-Emeric C, Flood KL, Lyles KW, Tanner SB, Watts NB, Curtis JR. Management of osteoporosis among home health and long-term care patients with a prior fracture. Southern Medical Journal. 102: 397-404. PMID 19279529 DOI: 10.1097/Smj.0B013E31819Bc1D3 |
0.37 |
|
| 2009 |
Teng GG, Curtis JR, Saag KG. Quality health care gaps in osteoporosis: how can patients, providers, and the health system do a better job? Current Osteoporosis Reports. 7: 27-34. PMID 19239827 DOI: 10.1007/S11914-009-0006-3 |
0.329 |
|
| 2009 |
Caplan L, Saag KG. Glucocorticoids and the risk of osteoporosis. Expert Opinion On Drug Safety. 8: 33-47. PMID 19236216 DOI: 10.1517/14740330802648194 |
0.361 |
|
| 2009 |
Cheng H, Gary LC, Curtis JR, Saag KG, Kilgore ML, Morrisey MA, Matthews R, Smith W, Yun H, Delzell E. Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 20: 1507-15. PMID 19189165 DOI: 10.1007/S00198-009-0835-Z |
0.355 |
|
| 2009 |
Siris ES, Selby PL, Saag KG, Borgström F, Herings RMC, Silverman SL. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. The American Journal of Medicine. 122. PMID 19187810 DOI: 10.1016/J.Amjmed.2008.12.002 |
0.379 |
|
| 2009 |
Curtis JR, Taylor AJ, Matthews RS, Ray MN, Becker DJ, Gary LC, Kilgore ML, Morrisey MA, Saag KG, Warriner A, Delzell E. "Pathologic" fractures: should these be included in epidemiologic studies of osteoporotic fractures? Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 20: 1969-72. PMID 19184268 DOI: 10.1007/S00198-009-0840-2 |
0.315 |
|
| 2009 |
Burnett-Bowie SM, Saag K, Sebba A, Papp AEd, Chen E, Rosenberg E, Greenspan SL. Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates. The Journal of Clinical Endocrinology and Metabolism. 94: 1097-1103. PMID 19141590 DOI: 10.1210/Jc.2008-1122 |
0.355 |
|
| 2009 |
Curtis JR, Mudano AS, Solomon DH, Xi J, Melton ME, Saag KG. Identification and validation of vertebral compression fractures using administrative claims data. Medical Care. 47: 69-72. PMID 19106733 DOI: 10.1097/Mlr.0B013E3181808C05 |
0.316 |
|
| 2009 |
Gaffo AL, Saag KG. Are glucocorticoids equivalent to NSAIDs for the treatment of gout flares Nature Reviews Rheumatology. 5: 12-13. PMID 19048008 DOI: 10.1038/Ncprheum0962 |
0.318 |
|
| 2009 |
Curtis JR, Westfall AO, Cheng H, Saag KG, Delzell E. RisedronatE and ALendronate intervention over three years (REALITY): Minimal differences in fracture risk reduction Osteoporosis International. 20: 973. PMID 18946630 DOI: 10.1007/S00198-008-0772-2 |
0.336 |
|
| 2009 |
Mudano AS, Bian J, Cope JU, Curtis JR, Gross TP, Allison JJ, Kim Y, Briggs D, Melton ME, Xi J, Saag KG. Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: A population-based cohort study Osteoporosis International. 20: 819-826. PMID 18797812 DOI: 10.1007/S00198-008-0745-5 |
0.38 |
|
| 2009 |
Furst DE, Saag KG, Melin JR. Strategies for treating rheumatoid arthritis: new guidelines from the ACR International Journal of Clinical Rheumatology. 4: 3-5. DOI: 10.2217/17584272.4.1.3 |
0.309 |
|
| 2009 |
Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrink P, Sambrook PN. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (health outcomes and reduced incidence with zoledronic acid once yearly trial): A multicentre, double-blind, double-dummy, randomized controlled trial Obstetrical and Gynecological Survey. 64: 521-523. DOI: 10.1097/01.Ogx.0000356937.03800.0F |
0.357 |
|
| 2009 |
Saag K, Devogelaer J, Mesenbrink P, Papanastasiou P, Reginster JL, Reid DM, Roux C, Sambrook P. Poster 43: Effect of Intravenous Zoledronic Acid on Lumbar Spine Bone Mineral Density Compared to Oral Risedronate in Subgroups of Patients Receiving Glucocorticoid Therapy Pm&R. 1. DOI: 10.1016/J.Pmrj.2009.08.060 |
0.32 |
|
| 2009 |
Saag K, Devogelaer J, Mesenbrink P, Papanastasiou P, Reginster JL, Reid DM, Roux C, Sambrook P. Poster 42: Effect of a Single Intravenous Infusion of Zoledronic Acid on Bone Turnover Markers Compared to Oral Risedronate Over 1 Year in Patients with Glucocorticoid-Induced Osteoporosis Pm&R. 1. DOI: 10.1016/J.Pmrj.2009.08.059 |
0.314 |
|
| 2009 |
Curtis J, Arora T, Becker D, Gary L, Kilgore M, Matthews R, Morrisey M, Saag K, Safford M, Taylor A, Delzell E. Is Withholding Osteoporosis Medication After Fracture Sometimes Rational? A Comparison of the Risk for Recurrent Fracture Versus Death Journal of Clinical Densitometry. 12: 380. DOI: 10.1016/J.Jocd.2009.07.008 |
0.342 |
|
| 2009 |
Sambrook P, Devogelaer J, Reginster J, Saag K, Roux C, Lau C, Papanastasiou P, Schoenborn-Kellenberger O, Maylandt K, Fashola T, Mesenbrink P, Reid D. Effect of a aingle i.v. infusion of zoledronic acid on bone turnover markers versus oral risedronate in patients with glucocorticoid-induced osteoporosis Bone. 44. DOI: 10.1016/J.Bone.2009.01.421 |
0.301 |
|
| 2009 |
Adami S, Boonen S, Cooper C, Diez-Perez A, Greenspan SL, LaCroix A, Saag KG, Silverman S, Watts NB, Wyman A, Siris ES. Failure to perceive increased risk of fracture in women aged 55 years and older. The global longitudinal study of osteoporosis in women Bone. 44. DOI: 10.1016/J.Bone.2009.01.237 |
0.33 |
|
| 2008 |
Cobaugh DJ, Angner E, Kiefe CI, Ray MN, Lacivita CL, Weissman NW, Saag KG, Allison JJ. Effect of racial differences on ability to afford prescription medications. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 65: 2137-43. PMID 18997143 DOI: 10.2146/Ajhp080062 |
0.683 |
|
| 2008 |
Saag KG. Bisphosphonates for osteoarthritis prevention: “Holy Grail” or not? Annals of the Rheumatic Diseases. 67: 1358-1359. PMID 18791054 DOI: 10.1136/Ard.2008.089912 |
0.311 |
|
| 2008 |
McDonough AK, Rosenthal RS, Cao X, Saag KG. The effect of thiazolidinediones on BMD and osteoporosis. Nature Clinical Practice. Endocrinology & Metabolism. 4: 507-13. PMID 18695700 DOI: 10.1038/Ncpendmet0920 |
0.348 |
|
| 2008 |
Miller PD, Delmas PD, Lindsay R, Watts NB, Luckey M, Adachi J, Saag K, Greenspan SL, Seeman E, Boonen S, Meeves S, Lang TF, Bilezikian JP. Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. The Journal of Clinical Endocrinology and Metabolism. 93: 3785-93. PMID 18682511 DOI: 10.1210/Jc.2008-0353 |
0.316 |
|
| 2008 |
Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison JJ, Suarez Almazor M, Bridges SL, Chatham WW, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis and Rheumatism. 59: 762-84. PMID 18512708 DOI: 10.1002/Art.23721 |
0.306 |
|
| 2008 |
Curtis JR, Westfall AO, Cheng H, Delzell E, Saag KG. Risk of hip fracture after bisphosphonate discontinuation: Implications for a drug holiday Osteoporosis International. 19: 1613-1620. PMID 18483689 DOI: 10.1007/S00198-008-0604-4 |
0.379 |
|
| 2008 |
Teng GG, Warriner A, Curtis JR, Saag KG. Improving quality of care in osteoporosis: opportunities and challenges. Current Rheumatology Reports. 10: 123-130. PMID 18460267 DOI: 10.1007/S11926-008-0022-9 |
0.366 |
|
| 2008 |
Curtis JR, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E. Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 23: 1435-41. PMID 18442318 DOI: 10.1359/Jbmr.080418 |
0.349 |
|
| 2008 |
Geusens PP, Roux CH, Reid DM, Lems WF, Adami S, Adachi JD, Sambrook PN, Saag KG, Lane NE, Hochberg MC. Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective. Nature Reviews Rheumatology. 4: 240-248. PMID 18398411 DOI: 10.1038/Ncprheum0773 |
0.363 |
|
| 2008 |
Patkar NM, Teng GG, Curtis JR, Saag KG. Association of infections and tuberculosis with antitumor necrosis factor alpha therapy. Current Opinion in Rheumatology. 20: 320-326. PMID 18388525 DOI: 10.1097/Bor.0B013E3282Fa74F7 |
0.303 |
|
| 2008 |
Curtis JR, Carbone L, Cheng H, Hayes B, Laster A, Matthews R, Saag KG, Sepanski R, Tanner SB, Delzell E. Longitudinal trends in use of bone mass measurement among older americans, 1999-2005. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 23: 1061-7. PMID 18302495 DOI: 10.1359/Jbmr.080232 |
0.356 |
|
| 2008 |
Kovac SH, Saag KG, Curtis JR, Allison J. Association of health-related quality of life with dual use of prescription and over-the-counter nonsteroidal antiinflammatory drugs. Arthritis and Rheumatism. 59: 227-33. PMID 18240185 DOI: 10.1002/Art.23336 |
0.304 |
|
| 2008 |
Saag KG, Shane E, Boonen S, Marin F, Donley DW, Taylor KA, Dalsky GP, Marcus R. Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis Obstetrical & Gynecological Survey. 63: 232-233. DOI: 10.1097/01.Ogx.0000310357.43258.F1 |
0.401 |
|
| 2008 |
Hayes B, Curtis J, Johnson KC, Laster A, Saag K, Sepanski R, Tanner B, Womack C, Carbone L. Impact of Medicare Cutbacks In DXA Reimbursement on Care of Patients At Risk For Fracture Journal of Clinical Densitometry. 11: 469. DOI: 10.1016/J.Jocd.2008.05.039 |
0.345 |
|
| 2007 |
Curtis JR, Xi J, Patkar N, Xie A, Saag KG, Martin C. Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists. Arthritis and Rheumatism. 56: 4226-7. PMID 18050253 DOI: 10.1002/Art.23050 |
0.352 |
|
| 2007 |
Fry RB, Ray MN, Cobaugh DJ, Weissman NW, Kiefe CI, Shewchuk RM, Saag KG, Curtis JR, Allison JJ. Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior. Arthritis and Rheumatism. 57: 1539-45. PMID 18050227 DOI: 10.1002/Art.23084 |
0.689 |
|
| 2007 |
Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, Dalsky GP, Marcus R. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. The New England Journal of Medicine. 357: 2028-39. PMID 18003959 DOI: 10.1056/Nejmoa071408 |
0.38 |
|
| 2007 |
Curtis JR, Kramer JM, Martin C, Saag KG, Patkar N, Shatin D, Burgess M, Xie A, Braun MM. Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-α antagonists Rheumatology. 46: 1688-1693. PMID 17938138 DOI: 10.1093/Rheumatology/Kem212 |
0.318 |
|
| 2007 |
MacLean CH, Pencharz JN, Saag KG. Quality indicators for the care of osteoarthritis in vulnerable elders. Journal of the American Geriatrics Society. 55: S383-91. PMID 17910561 DOI: 10.1111/J.1532-5415.2007.01346.X |
0.307 |
|
| 2007 |
Colon-Emeric CS, Lyles KW, House P, Levine DA, Schenck AP, Allison JJ, Gorospe J, Fermazin M, Oliver K, Curtis JR, Weissman NW, Xie A, Saag KG. Randomized Trial to Improve Fracture Prevention in Nursing Home Residents The American Journal of Medicine. 120: 886-892. PMID 17904460 DOI: 10.1016/J.Amjmed.2007.04.020 |
0.698 |
|
| 2007 |
Hoes JN, Jacobs JWG, Boers M, Boumpas D, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Silva JAPD, Esselens G, Guillevin L, Hafstrom I, Kirwan JR, Rovensky J, Russell A, ... Saag KG, et al. EULAR evidence based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Annals of the Rheumatic Diseases. 66: 1560-1567. PMID 17660219 DOI: 10.1136/Ard.2007.072157 |
0.326 |
|
| 2007 |
Curtis JR, Patkar NM, Xie A, Martin CK, Allison JJ, Saag MS, Shatin D, Saag KG. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis & Rheumatism. 56: 1125-1133. PMID 17393394 DOI: 10.1002/Art.22504 |
0.331 |
|
| 2007 |
Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, Kiefe CI, MacArthur M, Ockershausen T, Stewart E, Weissman N, Saag KG. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial. Archives of Internal Medicine. 167: 591-6. PMID 17389291 DOI: 10.1001/Archinte.167.6.591 |
0.708 |
|
| 2007 |
Saag K, Lindsay R, Kriegman A, Beamer E, Zhou W. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density Bone. 40: 1238-1243. PMID 17347063 DOI: 10.1016/J.Bone.2007.01.016 |
0.316 |
|
| 2007 |
Curtis JR, Saag KG. Prevention and treatment of glucocorticoid-induced osteoporosis Current Osteoporosis Reports. 5: 14-21. PMID 17320023 DOI: 10.1007/Bf02938618 |
0.41 |
|
| 2007 |
Harrold LR, Saag KG, Yood RA, Mikuls TR, Andrade SE, Fouayzi H, Davis J, Chan KA, Raebel MA, Worley AV, Platt R. Validity of gout diagnoses in administrative data. Arthritis Care and Research. 57: 103-108. PMID 17266097 DOI: 10.1002/Art.22474 |
0.315 |
|
| 2007 |
Colón-Emeric C, Lyles KW, Levine DA, House P, Schenck A, Gorospe J, Fermazin M, Oliver K, Alison J, Weisman N, Xie A, Curtis JR, Saag K. Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture. Osteoporosis International. 18: 553-559. PMID 17120179 DOI: 10.1007/S00198-006-0260-5 |
0.3 |
|
| 2007 |
Chaiamnuay S, Saag KG. Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates Reviews in Endocrine & Metabolic Disorders. 7: 101-112. PMID 17043761 DOI: 10.1007/S11154-006-9008-Y |
0.383 |
|
| 2007 |
Goemaere S, Liberman UA, Adachi JD, Hawkins F, Lane N, Saag KG, Schnitzer T, Kaufman JM, Malice MP, Carofano W, Daifotis A. Incidence of nonvertebral fractures in relation to time on treatment and bone density in glucocorticoid-treated patients: a retrospective approach. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 9: 170-5. PMID 17041453 DOI: 10.1097/01.Rhu.0000073586.28977.31 |
0.384 |
|
| 2007 |
Cafardi JM, Alarcón GS, Saag KG. Effect of reproductive factors on rheumatoid arthritis Future Rheumatology. 2: 177-183. DOI: 10.2217/17460816.2.2.177 |
0.305 |
|
| 2007 |
Bonnick S, Saag KG, Kiel DP, Mcclung M, Hochberg M, Burnett SM, Sebba A, Kagan R, Chen E, Thompson DE, Papp AED. Comparison of Weekly Treatment of Postmenopausal Osteoporosis with Alendronate Versus Risedronate Over Two Years Obstetrical & Gynecological Survey. 62: 35-36. DOI: 10.1097/01.Ogx.0000251009.57462.83 |
0.391 |
|
| 2007 |
Teng GG, Patkar NM, Saag KG. New directions in osteoporosis therapy: Intravenous ibandronate and denosumab Current Rheumatology Reports. 9: 47-49. DOI: 10.1007/S11926-007-0021-2 |
0.343 |
|
| 2006 |
Palonen KP, Saag KG. Improving the quality of clinical care for patients with osteoporosis Expert Review of Pharmacoeconomics & Outcomes Research. 6: 641-645. PMID 20528489 DOI: 10.1586/14737167.6.6.641 |
0.379 |
|
| 2006 |
Gaffo A, Saag KG, Curtis JR. Treatment of rheumatoid arthritis American Journal of Health-System Pharmacy. 63: 2451-2465. PMID 17158693 DOI: 10.2146/Ajhp050514 |
0.31 |
|
| 2006 |
Colón-Emeric CS, Saag KG. Osteoporotic fractures in older adults. Best Practice & Research: Clinical Rheumatology. 20: 695-706. PMID 16979533 DOI: 10.1016/J.Berh.2006.04.004 |
0.333 |
|
| 2006 |
Teng GG, Nair R, Saag KG. Pathophysiology, clinical presentation and treatment of gout. Drugs. 66: 1547-1563. PMID 16956303 DOI: 10.2165/00003495-200666120-00002 |
0.352 |
|
| 2006 |
Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, Bakst AW. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clinic Proceedings. 81: 925-34. PMID 16835972 DOI: 10.4065/81.7.925 |
0.335 |
|
| 2006 |
Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout Arthritis Research & Therapy. 8: 1-7. PMID 16820041 DOI: 10.1186/Ar1907 |
0.33 |
|
| 2006 |
Curtis JR, Westfall AO, Allison JJ, Freeman A, Saag KG. Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users Osteoporosis International. 17: 1268-1274. PMID 16724286 DOI: 10.1007/S00198-006-0136-8 |
0.326 |
|
| 2006 |
Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, Chan KA, Roblin D, Raebel MA, Worley AV, Platt R, Saag KG. Sex differences in gout epidemiology: evaluation and treatment Annals of the Rheumatic Diseases. 65: 1368-1372. PMID 16644784 DOI: 10.1136/Ard.2006.051649 |
0.312 |
|
| 2006 |
Bonnick S, Saag KG, Kiel DP, McClung M, Hochberg M, Burnett SM, Sebba A, Kagan R, Chen E, Thompson DE, de Papp AE. Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years. The Journal of Clinical Endocrinology and Metabolism. 91: 2631-7. PMID 16636120 DOI: 10.1210/Jc.2005-2602 |
0.367 |
|
| 2006 |
Abdolrasulnia M, Weichold N, Shewchuk R, Saag K, Cobaugh DJ, LaCivita C, Weissman N, Allison J. Agreement between medical record documentation and patient-reported use of nonsteroidal antiinflammatory drugs. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 63: 744-7. PMID 16595815 DOI: 10.2146/Ajhp050409 |
0.682 |
|
| 2006 |
Heffernan MP, Saag KG, Robinson JK, Callen JP. Prevention of osteoporosis associated with chronic glucocorticoid therapy: Commentary Journal of the American Medical Association. 295: 1300-1303. PMID 16541489 DOI: 10.1001/Jama.295.11.1300 |
0.372 |
|
| 2006 |
Curtis JR, Smith B, Weaver M, Landers K, Lopez-Ben R, Raper JL, Saag M, Venkataraman R, Saag KG. Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy. Aids Research and Human Retroviruses. 22: 125-31. PMID 16478393 DOI: 10.1089/Aid.2006.22.125 |
0.303 |
|
| 2006 |
Silva JAPD, Jacobs JWG, Kirwan JR, Boers M, Saag KG, Inês LBS, Koning EJPd, Buttgereit F, Cutolo M, Capell H, Rau R, Bijlsma JWJ. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data Annals of the Rheumatic Diseases. 65: 285-293. PMID 16107513 DOI: 10.1136/Ard.2005.038638 |
0.315 |
|
| 2006 |
Nair R, Saag KG. The use of low- dose glucocorticoids for the treatment of early rheumatoid arthritis: What can we learn about bone effects of glucocorticoids from randomized controlled trials? Current Rheumatology Reports. 8: 47-48. DOI: 10.1007/S11926-006-0024-4 |
0.371 |
|
| 2005 |
Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A, Spettell CM, Weissman NW, Wilke S, Saag KG. Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients Arthritis and Rheumatism. 52: 2485-2494. PMID 16052570 DOI: 10.1002/Art.21194 |
0.721 |
|
| 2005 |
King AB, Saag KG, Burge RT, Pisu M, Goel N. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 16: 1545-57. PMID 15942702 DOI: 10.1007/S00198-005-1869-5 |
0.38 |
|
| 2005 |
Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: Results from the UK General Practice Research Database (GPRD) Rheumatology. 44: 1038-1042. PMID 15870145 DOI: 10.1093/Rheumatology/Keh679 |
0.327 |
|
| 2005 |
Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR, Saag KG. Gout epidemiology: Results from the UK General Practice Research Database, 1990-1999 Annals of the Rheumatic Diseases. 64: 267-272. PMID 15647434 DOI: 10.1136/Ard.2004.024091 |
0.334 |
|
| 2005 |
Bijlsma JW, Saag KG, Buttgereit F, da Silva JA. Developments in glucocorticoid therapy. Rheumatic Diseases Clinics of North America. 31: 1-17, vii. PMID 15639052 DOI: 10.1016/J.Rdc.2004.10.003 |
0.305 |
|
| 2004 |
Saag KG. Prevention of glucocorticoid-induced osteoporosis. Southern Medical Journal. 97: 555-558. PMID 15255421 DOI: 10.1097/00007611-200406000-00008 |
0.364 |
|
| 2003 |
Merlino LA, Cerhan JR, Criswell LA, Mikuls TR, Saag KG. Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women Seminars in Arthritis and Rheumatism. 33: 72-82. PMID 14625816 DOI: 10.1016/S0049-0172(03)00084-2 |
0.32 |
|
| 2003 |
Bijlsma JWJ, Boers M, Saag KG, Furst DE. Glucocorticoids in the treatment of early and late RA Annals of the Rheumatic Diseases. 62: 1033-1037. PMID 14583563 DOI: 10.1136/Ard.62.11.1033 |
0.312 |
|
| 2003 |
Mudano AS, Casebeer L, Patino F, Allison JJ, Weissman NW, Kiefe CI, Person S, Gilbert D, Saag KG. Racial disparities in osteoporosis prevention in a managed care population. Southern Medical Journal. 96: 445-51. PMID 12911182 DOI: 10.1097/01.Smj.0000053918.93363.B0 |
0.703 |
|
| 2003 |
Saag KG. Glucocorticoid-induced osteoporosis. Endocrinology and Metabolism Clinics of North America. 32: 135-157. PMID 12699296 DOI: 10.1016/S0889-8529(02)00064-6 |
0.362 |
|
| 2002 |
Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, et al. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Arthritis and Rheumatism. 46: 2020-8. PMID 12209503 DOI: 10.1002/Art.10427 |
0.302 |
|
| 2002 |
Saag KG. Glucocorticoid use in rheumatoid arthritis Current Rheumatology Reports. 4: 218-225. PMID 12010606 DOI: 10.1007/S11926-002-0068-Z |
0.353 |
|
| 2002 |
Mikuls TR, Cerhan JR, Criswell LA, Merlino L, Mudano AS, Burma M, Folsom AR, Saag KG. Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis and Rheumatism. 46: 83-91. PMID 11817612 DOI: 10.1002/1529-0131(200201)46:1<83::Aid-Art10042>3.0.Co;2-D |
0.32 |
|
| 2002 |
Mikuls TR, Saag KG, Criswell LA, Merlino LA, Kaslow RA, Shelton BJ, Cerhan JR. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: Results from the Iowa Women's Health Study Annals of the Rheumatic Diseases. 61: 994-999. DOI: 10.1136/Ard.61.11.994 |
0.315 |
|
| 2001 |
Mikuls TR, Kahn D, Utrie PC, Miller SJ, Koehnke R, Goeckeler W, Saag KG. Samarium-153-EDTMP in the treatment of refractory rheumatoid arthritis. Scandinavian Journal of Rheumatology. 30: 356-359. PMID 11846055 DOI: 10.1080/030097401317148561 |
0.303 |
|
| 2001 |
Kaboli PJ, Doebbeling BN, Saag KG, Rosenthal GE. Use of complementary and alternative medicine by older patients with arthritis: A population-based study Arthritis Care and Research. 45: 398-403. PMID 11501729 DOI: 10.1002/1529-0131(200108)45:4<398::Aid-Art354>3.0.Co;2-I |
0.334 |
|
| 2001 |
Mikuls TR, Saag KG. Comorbidity in rheumatoid arthritis. Rheumatic Diseases Clinics of North America. 27: 283-303. PMID 11396093 DOI: 10.1016/S0889-857X(05)70202-7 |
0.32 |
|
| 2001 |
Merlino LA, Bagchi I, Taylor TN, Utrie P, Chrischilles E, Sumner W, Mudano A, Saag KG. Preference for fractures and other glucocorticoid-associated adverse effects among rheumatoid arthritis patients. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 21: 122-32. PMID 11310945 DOI: 10.1177/0272989X0102100205 |
0.342 |
|
| 2001 |
Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, et al. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis and Rheumatism. 44: 202-11. PMID 11212161 DOI: 10.1002/1529-0131(200101)44:1<202::Aid-Anr27>3.0.Co;2-W |
0.363 |
|
| 2000 |
Osiri M, Saag KG, Ford AM, Moreland LW. Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis. Jcr-Journal of Clinical Rheumatology. 6: 117-122. PMID 19078458 DOI: 10.1097/00124743-200006000-00001 |
0.378 |
|
| 2000 |
Saag K, van der Heijde D, Fisher C, Samara A, DeTora L, Bolognese J, Sperling R, Daniels B. Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group. Archives of Family Medicine. 9: 1124-34. PMID 11115219 DOI: 10.1001/Archfami.9.10.1124 |
0.309 |
|
| 1998 |
Criswell L, Saag K, Sems KM, Welch V, Shea B, Wells GA, Suarez‐Almazor ME. Moderate-term, low-dose corticosteroids for rheumatoid arthritis. Cochrane Database of Systematic Reviews. CD001158. PMID 10796420 DOI: 10.1002/14651858.Cd001158 |
0.333 |
|
| 1998 |
Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. The New England Journal of Medicine. 339: 292-9. PMID 9682041 DOI: 10.1056/Nejm199807303390502 |
0.302 |
|
| 1997 |
Saag KG. Low-dose corticosteroid therapy in rheumatoid arthritis: balancing the evidence. The American Journal of Medicine. 103. PMID 9455967 DOI: 10.1016/S0002-9343(97)90006-1 |
0.322 |
|
| 1996 |
Burma MR, Rachow JW, Saag KG, Kolluri S. Methotrexate patient education: A quality improvement study Arthritis Care and Research. 9: 216-222. PMID 8971231 DOI: 10.1002/1529-0131(199606)9:3<216::Aid-Anr1790090310>3.0.Co;2-5 |
0.31 |
|
| 1996 |
Saag KG, Criswell LA, Sems KM, Nettleman MD, Kolluri S. Low‐dose corticosteroids in rheumatoid arthritis. A meta‐analysis of their moderate‐term effectiveness Arthritis & Rheumatism. 39: 1818-1825. PMID 8912503 DOI: 10.1002/Art.1780391107 |
0.325 |
|
| 1994 |
Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE. Low Dose Long-Term Corticosteroid Therapy in Rheumatoid Arthritis: An Analysis of Serious Adverse Events The American Journal of Medicine. 96: 115-123. PMID 8109596 DOI: 10.1016/0002-9343(94)90131-7 |
0.328 |
|
| Show low-probability matches. |